dihydrorhodamine 123 has been researched along with pioglitazone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, J; Hui, X; Liu, D; Sun, J; Wang, W; Wang, X; Yao, H; Ying, W; Zhou, Q | 1 |
1 other study(ies) available for dihydrorhodamine 123 and pioglitazone
| Article | Year |
|---|---|
Low-Dose Pioglitazone does not Increase ROS Production in Chronic Granulomatous Disease Patients with Severe Infection.
Topics: Adolescent; Child; Child, Preschool; Granulomatous Disease, Chronic; Humans; Male; Mutation; NADPH Oxidase 2; NADPH Oxidases; Pioglitazone; Reactive Oxygen Species; Rhodamines | 2020 |